Terms: = Kidney tumors AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
14 results:
1. Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.
Zheng J; Li S; Zhao Y; Tao Z; Li L; Li Z; Li M; Chen X
BMJ Open; 2022 Sep; 12(9):e062129. PubMed ID: 36581979
[TBL] [Abstract] [Full Text] [Related]
2. Volumetric Quantitative Contrast-enhanced Ultrasonography Evaluation of Complex Renal Cysts: An Adjunctive Metric to the Bosniak Classification System to Predict Malignancy.
Chandrasekar T; Clark CB; Gomella A; Wessner CE; Wang S; Nam K; Liu JB; Forsberg F; Lyshchik A; Halpern E; Mark JR; Lallas CD; Gomella LG; Kania L; Trabulsi EJ; Eisenbrey JR
Eur Urol Focus; 2023 Mar; 9(2):336-344. PubMed ID: 36319560
[TBL] [Abstract] [Full Text] [Related]
3. Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
McGregor B; Geynisman DM; Burotto M; Porta C; Suarez C; Bourlon MT; Del Tejo V; Du EX; Yang X; Sendhil SR; Betts KA; Huo S
Oncologist; 2023 Jan; 28(1):72-79. PubMed ID: 36124890
[TBL] [Abstract] [Full Text] [Related]
4. Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States.
Liao W; Lei W; Feng M; Yang Y; Wu Q; Zhou K; Bai L; Wen F; Li Q
Adv Ther; 2021 Dec; 38(12):5662-5670. PubMed ID: 34664194
[TBL] [Abstract] [Full Text] [Related]
5. Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.
Zhou X; Fu G; Zu X; Xu Z; Li HT; D'souza A; Tulpule V; Quinn DI; Bhowmick NA; Weisenberger DJ; Liang G; Chen J
Urol Oncol; 2022 Jan; 40(1):12.e13-12.e22. PubMed ID: 34454823
[TBL] [Abstract] [Full Text] [Related]
6. Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.
Bracarda S; Bamias A; Casper J; Negrier S; Sella A; Staehler M; Tarazi J; Felici A; Rosbrook B; Jardinaud-Lopez M; Escudier B
Clin Genitourin Cancer; 2019 Jun; 17(3):e689-e703. PubMed ID: 31072748
[TBL] [Abstract] [Full Text] [Related]
7. Time to initial cancer treatment in the United States and association with survival over time: An observational study.
Khorana AA; Tullio K; Elson P; Pennell NA; Grobmyer SR; Kalady MF; Raymond D; Abraham J; Klein EA; Walsh RM; Monteleone EE; Wei W; Hobbs B; Bolwell BJ
PLoS One; 2019; 14(3):e0213209. PubMed ID: 30822350
[TBL] [Abstract] [Full Text] [Related]
8. Estimation of Future Cancer Burden Among Rescue and Recovery Workers Exposed to the World Trade Center Disaster.
Singh A; Zeig-Owens R; Moir W; Hall CB; Schwartz T; Vossbrinck M; Jaber N; Webber MP; Kelly KJ; Ortiz V; Koffler E; Prezant DJ
JAMA Oncol; 2018 Jun; 4(6):828-831. PubMed ID: 29710126
[TBL] [Abstract] [Full Text] [Related]
9. A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As
Li YL; Jin YF; Liu XX; Li HJ
Ren Fail; 2018 Nov; 40(1):331-339. PubMed ID: 29633893
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal tumors.
Peyronnet B; Seisen T; Oger E; Vaessen C; Grassano Y; Benoit T; Carrouget J; Pradère B; Khene Z; Giwerc A; Mathieu R; Beauval JB; Nouhaud FX; Bigot P; Doumerc N; Bernhard JC; Mejean A; Patard JJ; Shariat S; Roupret M; Bensalah K;
Ann Surg Oncol; 2016 Dec; 23(13):4277-4283. PubMed ID: 27411552
[TBL] [Abstract] [Full Text] [Related]
11. Risk of a Second kidney Carcinoma Following Childhood Cancer: Role of Chemotherapy and Radiation Dose to kidneys.
de Vathaire F; Scwhartz B; El-Fayech C; Allodji RS; Escudier B; Hawkins M; Diallo I; Haddy N
J Urol; 2015 Nov; 194(5):1390-5. PubMed ID: 26143112
[TBL] [Abstract] [Full Text] [Related]
12. Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data.
Iacovelli R; Santoni M; Verzoni E; Grassi P; Testa I; de Braud F; Cascinu S; Procopio G
Clin Genitourin Cancer; 2015 Apr; 13(2):137-41. PubMed ID: 25160521
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: a registry-based analysis.
Buchler T; Bortlicek Z; Poprach A; Kubackova K; Kiss I; Zemanova M; Fiala O; Dusek L; Vyzula R; Melichar B;
Urol Oncol; 2014 Jul; 32(5):569-75. PubMed ID: 24629497
[TBL] [Abstract] [Full Text] [Related]
14. Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer.
Ueda S; Hironaka S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
Gastric Cancer; 2006; 9(3):203-7. PubMed ID: 16952039
[TBL] [Abstract] [Full Text] [Related]
